fanconi aneamia

Short notes about interesting topics
doody
Member
Member
Posts: 28
Joined: 28 Jul 2013, 15:32
University: Nile Valley University
Degree (College): MBBS
Graduation Year: 2012
Post-Graduation: NIL
Plan \ Working On: Finishing Medical School
Speciality: No Plans Yet
Job Title: House Officer (intern)
Work Place: khartoum teaching hospital
Has thanked: 22 times
Been thanked: 3 times
Contact:

fanconi aneamia

Unread post by doody »

FA) is a genetic disease with an incidence of 1 per 350,000 births, with a higher frequency in Ashkenazi Jews and Afrikaners in South Africa.[1]

FA is the result of a genetic defect in a cluster of proteins responsible for DNA repair. As a result, the majority of FA patients develop cancer, most often acute myelogenous leukemia, and 90% develop bone marrow failure (the inability to produce blood cells) by age 40. About 60-75% of FA patients have congenital defects, commonly short stature, abnormalities of the skin, arms, head, eyes, kidneys, and ears, and developmental disabilities. Around 75% of FA patients have some form of endocrine problem, with varying degrees of severity. Median age of death was 30 years in 2000.[2]

Treatment with androgens and hematopoietic (blood cell) growth factors can help bone marrow failure temporarily, but the long-term treatment is bone marrow transplant if a donor is available.[2]

Because of the genetic defect in DNA repair, cells from people with FA are sensitive to drugs that treat cancer by DNA crosslinking, such as mitomycin C.

The disease is named after the Swiss pediatrician who originally described this disorder, Guido Fanconi.[3][4] It should not be confused with Fanconi syndrome, a kidney disorder also named after Fanconi :P
Post Reply

Return to “Notes”